Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT) (Q81629371)
Jump to navigation
Jump to search
scientific article published on 01 April 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT) |
scientific article published on 01 April 2005 |
Statements
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT) (English)
Dafna Gladman
Arthur Kavanaugh
Christian E Antoni
Bruce Kirkham
Zuhre Tutuncu
Gerd R Burmester
Udo Schneider
Daniel E Furst
Jerry Molitor
Edward Keystone
Bernhard Manger
Siegfried Wassenberg
Ralf Weier
Daniel J Wallace
Michael H Weisman
Joachim R Kalden